BioCrossroads publishes directory of Indiana health and life sciences data organizations

2021-04-05T16:47:43-04:00July 7, 2020|

INDIANAPOLIS (July 7, 2020) – Indiana’s industry, government, health systems, academia, and digital health startups have tremendous data and technology resources which are driving transformative healthcare and life sciences work locally and globally. To capture all of those assets in a one-stop spot, BioCrossroads today published its Book of Data and Organizations, a directory of Indiana enterprises in the health-data intersection. The directory includes snapshots of ten organizations who control data assets – data sets, data talent, and/or data technology. The organization profiles answer: Who has what data? How can this data be accessed? Where does the data analysis talent reside? What data technologies and capabilities exist? What are the key projects currently in process? What are the future projects and opportunities for engagement? “Indiana has valuable and innovative life sciences and healthcare data initiatives and organizations that we’re highlighting through this [...]

Indiana’s life sciences industry ranks among the top 10 in national report

2021-04-05T16:47:43-04:00June 9, 2020|

INDIANAPOLIS (June 9, 2020) – Seven Indiana cities are recognized for their national life science strengths, according to Biotechnology Industry Organization (BIO) and TEConomy Partners’ biennial survey of the U.S. life sciences industry released today. Bloomington, Evansville, Indianapolis, Lafayette, Michigan City, South Bend and Terre Haute are identified in the report as having significant life sciences activity. Lafayette is one of only seven cities in the U.S to have employment specializations in four of the five industry subsectors. Bloomington and Indianapolis have employment specializations in three of the five industry subsectors (two of only 23 cities in the U.S. with that distinction). The report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities, measures growth in the bioscience sector (Agricultural Feedstock and Chemicals, Drugs and Pharmaceuticals, Medical Devices and Research, Testing and Medical Laboratories and Bioscience-related Distribution) from [...]

$9.1 billion of capital accessed by Indiana life sciences companies in 2019

2021-04-05T16:47:43-04:00April 22, 2020|

INDIANAPOLIS (April 22, 2020) – BioCrossroads today released a new report which details the sources and amounts of capital supporting Indiana’s life sciences sector in 2019. An impressive $9.1 billion in capital was accessed by Indiana life sciences companies in 2019: $8.6 million Small Business Innovation Research (SBIR) grants were awarded to 21 companies; $177 million in venture capital was invested in 37 companies; $178.7 million was accessed through public markets by two companies; and, More than $8.7 billion was spent to acquire innovation, representing eight transactions. Indiana’s life sciences companies raised over $360 million, excluding the significant funding represented by mergers and acquisitions, in 2019.  These funds support innovation to discover and develop new therapies for diseases. “Having access to multiple capital investment vehicles fuels Indiana’s diverse and vibrant life sciences industry, which adds to the strength of the [...]

BioCrossroads launches 2019 Annual Report

2021-04-05T16:47:43-04:00April 14, 2020|

Indiana’s life sciences industry keeps evolving, expanding and making new discoveries. The 2019 BioCrossroads Annual Report outlines how companies made acquisitions and invested in their local operations; new organizations opened facilities in Indiana, bringing innovation and hundreds of new jobs to the landscape; and start-ups received venture funding to move their products forward. The result is a vibrant and growing Indiana life sciences sector that is 2,157 companies and 56,575 people strong. [READ MORE]

BioCrossroads announces DataX BioInnovation Challenge winners

2021-04-05T16:47:43-04:00March 27, 2020|

INDIANAPOLIS (March 27, 2020) –BioCrossroads today announced the winners of their DataX BioInnovation Challenge, a competition where innovators used data sets to identify and investigate a hypothesis aimed at improving two Indiana health issues – diabetes and opioid abuse. The Challenge was created to intersect life sciences and data research and encourage new ways of investigating traditional disease biology and public health outcomes’ questions. Founded on the premise that asking critical questions can leverage publicly available data sets, the Challenge sought to foster new solutions. Indiana Poison Center at IU Health won the diabetes challenge with a prize of $10,000. Their experiment is focused on the unintentional ingestion of Type II diabetes oral medications which can cause devastating hypoglycemia in children and adults. They will determine exposure rates of unintentional type II diabetes medications in both children and adults, as [...]

Indiana’s life sciences industry continues to grow; Number of companies and workforce rank state as one of top five in U.S.

2021-04-05T16:47:43-04:00March 24, 2020|

INDIANAPOLIS (March 24, 2020) -- Indiana’s life sciences industry keeps evolving, expanding, and making new discoveries. In 2019, companies made acquisitions and invested in their local operations; new organizations opened facilities in Indiana, bringing innovation and hundreds of new jobs to the landscape; and start-ups received venture funding to move their products forward. The result is a vibrant and growing Indiana life sciences sector. The sector showed notable growth in several areas as it continues to compete with coastal hubs in the size of its workforce, number of companies and productivity. Now 2,1571 companies and 56,5751 people strong (increases over previous years), the state continues to rank as one of the five most concentrated life sciences states in the United States. For the ninth straight year, Indiana is ranked as the second highest exporter of life sciences products in the U.S with more than $10.5 billion2 in exports, according to [...]

BioCrossroads is supported by a $2.9 million grant from Lilly Endowment to advance the growth and awareness of life sciences in Indiana through 2021

2021-04-05T16:47:43-04:00March 4, 2020|

INDIANAPOLIS (March 4, 2020) – BioCrossroads has announced a two-year, $2.9 million grant from Lilly Endowment Inc. to the Central Indiana Corporate Partnership Foundation for the continued support of the charitable, educational and scientific activities of BioCrossroads. BioCrossroads, an initiative of the Central Indiana Corporate Partnership, promotes the growth and development of life sciences in Indiana. Since its founding in 2002, it has supported strategies to strengthen Indiana’s existing corporate and university capabilities in the life sciences and has expanded opportunities in the sector by encouraging new business development. “The accelerated pace of science and technology is quickly changing the life sciences ecosystem in Indiana and across the globe,” said Patty Martin, president and CEO of BioCrossroads. “It’s critical for BioCrossroads to continue increasing our capacity for progress in this space through connecting collaborators, investing in innovative companies and educating Hoosiers about [...]

BioCrossroads releases new report on advanced analytics and artificial intelligence focused on Indiana’s industry needs and university capabilities

2021-04-05T16:47:43-04:00January 16, 2020|

INDIANAPOLIS (Jan. 16, 2020) – BioCrossroads today released a new report from TEConomy Partners titled Artificial Intelligence and Advanced Analytics in Indiana:  An Initial Discussion of Industry Needs and University Capabilities. TEConomy conducted a series of interviews with major employers in Indiana along with leadership at Indiana University (IU), Purdue University (Purdue) and the University of Notre Dame (Notre Dame) to generate their findings, perspectives and recommendations.  The study finds that technological change is affecting our economy at an unprecedented pace and is driving significant investments by Indiana’s industry partners and research universities to ensure that they stay ahead of the curve.  However, there is limited coordination between industry and academia leaving missed opportunities to leverage investment, recruit and retain talent, and drive economic growth for the state. “Given the speed of change in the advanced analytics space, we wanted [...]

Data and healthcare executive Darshan Shah joins BioCrossroads as Senior Vice President / Chief Data Officer

2021-04-05T16:47:43-04:00January 6, 2020|

Darshan Shah, senior vice president and chief data officer, BioCrossroads INDIANAPOLIS (Jan. 6, 2020) – BioCrossroads announces that accomplished data and healthcare leader Darshan Shah has joined the organization as senior vice president/chief data officer. Shah brings the organization two decades of proven success in strategically guiding healthcare and life sciences organizations in a variety of functions including operations, finance, quality, engineering and sales. He joins BioCrossroads after serving as chief data officer for the State of Indiana and executive director of the Management and Performance Hub (MPH). As a result of his vision and leadership, MPH is a national leader in transforming state government through the use of data and analytics. “The life sciences sector is driven by data and analytics. Darshan has a deep understanding and passion for finding data-informed solutions that will be invaluable to [...]

BioCrossroads welcomes distinguished new members to Board of Directors, Executive Committee

2021-04-05T16:47:43-04:00December 17, 2019|

Dan Peterson, Vice President of Industry and Government Affairs for Cook Group; BioCrossroads Board Chair Dan Peterson, Vice President of Industry and Government Affairs for Cook Group; BioCrossroads Board Chair INDIANAPOLIS (Dec. 17, 2019) – BioCrossroads announces that Dan Peterson, vice president of Industry and Government Affairs for Cook Group, will lead the board of directors. In addition, seven new members will be joining the board: Dr. Richard DiMarchi, Indiana University; Dr. Ruth Gimeno, Eli Lilly and Company; Cris Johnston, State of Indiana; Marcela Kirberger, Roche Diagnostics Corporation North America; Dr. Theresa Mayer, Purdue University; Dr. Michael Mirro, Parkview Health; and Ron Stiver, IU Health. Stiver will also join the Executive Committee for the organization. “Dan Peterson has played an integral role in the advancement of BioCrossroads’ initiatives and in the Indiana life sciences community as a whole,” [...]

Go to Top